In its earliest, most curable stage, prostate cancer has no symptoms, according to Rebecca von Goetz, executive vice-president of Prostate Cancer Canada (PCC). More than 90 per cent of prostate cancer cases are curable if detected and treated in their …
See all stories on this topic »

Bone health critical issue for men with prostate cancer

"I treat many of these men who are unaware of their risk of prostate cancer and are often diagnosed at later stages of the disease." When an African-American man is diagnosed with prostate cancer, he often has a more advanced level of the disease.
See all stories on this topic »

Catching a killer quicker: Two new prostate cancer tests

Dr. Wei: Part of it is there is a huge amount of publicity about prostate cancer and this has just been growing over the years. There's been particularly a lot of press recently about overtreatment and the burden to patients who get treated because of … See all stories on this topic »

KSAT San Antonio

Patient takes stand against Highmark

By Friday, the health insurer had done a complete turnaround and agreed to pay for Patel's full treatment, spokesman Aaron Billger told me. Highmark's change of heart, however, won't apply to other prostate cancer patients in the same predicament as …
See all stories on this topic »

'Next Generation' cancer treatment ready for clinical trials

In the Journal of Biological Chemistry, published today, the researchers outline how these new agents increase the levels of a molecule (NDRG1) which inhibits the spread of cancer, including prostate and colon cancers. "Together with a …
Medical Xpress – latest medical…

Health Outcomes: Robotic Surgery, Prostate Cancer Treatment …

The diffusion of robotic surgery technology has coincided with a rapid period of growth in surgical treatment of prostate cancer, and this has raised questions of …
www.mskcc.org/…/robotic-surgery-prostate-treatment-p

How effective is cryotherapy for treating prostate cancer? | HIFU …

However, like other forms of treatments available for prostate cancer, it has never undergone an FDA trial or formal approval, but was “grandfathered” approved …
www.hifumedicalexpert.com/blog/?p=225

Men Health update covering New BPH, prostate cancer treatments …

Funded by the Foundation for research at Fox Chase Cancer Center found that pulsed MR-guided focused ultrasound enhances the delivery of chemotherapy …
thedesignatedgeek.com/men-health-update-covering-new-bph…

A better test for prostate cancer? – Post Bulletin

One of the problems with prostate cancer therapy is the decision of whether to do "watchful waiting" or to treat the cancer aggressively. Treatment can cause …
www.postbulletin.com/news/stories/display.php?id=1496944

Transurethral Hyperthermia Treatment in Germany Clinics foe …

Has anybody or know anyone who has had this transutheral hyperthermia treatment at these german clinics? I am hesitant, there isn't alot of information.
www.healingwell.com/community/default.aspx?f=35&m…

he signs of cancer, or if you are experiencing the effects of cancer, there is a whole world of information that you need to tap into to understand what to expect. Learning how to manage cancer is a is key to your medical treatments and learning how to live with it. The following tips will play an important role in your mental, emotional and physical well being.

Understand your cancer diagnosis. Once you have been diagnosed with cancer, arm yourself with information. Write down a number of questions to ask your doctor, including treatment options, side effects of treatment, whether the cancer can be cured, and potential for recurrence. There is also a vast amount of advice online, but always check with your doctor as to whether this information is correct.

But a prominent urologist is now telling prostate cancer patients – forget the prostactecomy. What he means is, it's time for long-term studies to “scientifically, objectively and reliably inform patients as to when and how to treat localized prostate …
See all stories on this topic »

Most cases of prostate cancer curable if detected and treated early

In its earliest, most curable stage, prostate cancer has no symptoms, according to Rebecca von Goetz, executive vice-president of Prostate Cancer Canada (PCC). More than 90 per cent of prostate cancer cases are curable if detected and treated in their …
See all stories on this topic »

Bone health critical issue for men with prostate cancer

"I treat many of these men who are unaware of their risk of prostate cancer and are often diagnosed at later stages of the disease." When an African-American man is diagnosed with prostate cancer, he often has a more advanced level of the disease.
See all stories on this topic »

Catching a killer quicker: Two new prostate cancer tests

Dr. Wei: Part of it is there is a huge amount of publicity about prostate cancer and this has just been growing over the years. There's been particularly a lot of press recently about overtreatment and the burden to patients who get treated because of … See all stories on this topic »

KSAT San Antonio

Patient takes stand against Highmark

By Friday, the health insurer had done a complete turnaround and agreed to pay for Patel's full treatment, spokesman Aaron Billger told me. Highmark's change of heart, however, won't apply to other prostate cancer patients in the same predicament as …
See all stories on this topic »

'Next Generation' cancer treatment ready for clinical trials

In the Journal of Biological Chemistry, published today, the researchers outline how these new agents increase the levels of a molecule (NDRG1) which inhibits the spread of cancer, including prostate and colon cancers. "Together with a …
Medical Xpress – latest medical…

Health Outcomes: Robotic Surgery, Prostate Cancer Treatment …

The diffusion of robotic surgery technology has coincided with a rapid period of growth in surgical treatment of prostate cancer, and this has raised questions of …
www.mskcc.org/…/robotic-surgery-prostate-treatment-p

How effective is cryotherapy for treating prostate cancer? | HIFU …

However, like other forms of treatments available for prostate cancer, it has never undergone an FDA trial or formal approval, but was “grandfathered” approved …
www.hifumedicalexpert.com/blog/?p=225

Men Health update covering New BPH, prostate cancer treatments …

Funded by the Foundation for research at Fox Chase Cancer Center found that pulsed MR-guided focused ultrasound enhances the delivery of chemotherapy …
thedesignatedgeek.com/men-health-update-covering-new-bph…

A better test for prostate cancer? – Post Bulletin

One of the problems with prostate cancer therapy is the decision of whether to do "watchful waiting" or to treat the cancer aggressively. Treatment can cause …
www.postbulletin.com/news/stories/display.php?id=1496944

mportant for cancer patients to research all of the current treatments in order to find out which treatment options are most effective and to understand what each treatment entails. This article contains a number of cancer tips.

Keep your stress under control. Too much stress has a negative impact on overall health and quality of life. Having too much stress causes some people to turn to unhealthy methods of coping, these methods can raise your cancer risk. It is important to find healthy ways to manage your stress. Take up a hobby or some regular exercise.

If you have figured out your family’s medical history as it pertains to cancer, you should talk to the professionals about what you can do going forward. Cancer specialists will know exactly what steps you can take to make sure that the disease is caught in time so that you can lead a normal, healthy life.

Focus on having a healthy diet during your cancer treatment. Eating better will give you more energy for everything that you are going through. It will also help you feel less stressed because your body will have the fuel it needs for the day. Research has shown that eating well may also extend your life.

A great tip for coping with cancer is to anticipate the physical changes you or your loved one will go through. If you research what will happen with your type of cancer and treatment, you will know what to expect and can prepare yourself mentally for the changes that will come.

As stated before, millions of people worldwide suffer from cancer. It’s a sad truth, yet being a cancer sufferer does not not mean that you cannot expect a great quality of life. You’ve just seen a few of the many great hints that are available to help you or a loved one to deal with this challenge. With a positive attitude and diligent effort, cancer can be fought effectively.

The multi-step Prostate Cancer Risk Calculator, www.prostatecancer-riskcalculator.com*, has been created by the founders of the European Randomized Study of Screening for Prostate Cancer (ERSPC). It is easy and simple for people to use.
See all stories on this topic »

ZYTIGA® (abiraterone acetate) Data to be Presented at 2012 American Society of …

Interim analysis (IA) results of COU-AA-302, a randomized, phase 3 study of abiraterone acetate (AA) in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) (Abstract LBA 4518)Clinical Science Symposium: New …
See all stories on this topic »

Bone health critical issue for men with prostate cancer

When an African-American man is diagnosed with prostate cancer, he often has a more advanced level of the disease. In fact, a study looking at how prostate cancer can spread to other parts of the body found that African-American men were more likely …
See all stories on this topic »

Charlie Wilson's fight against prostate cancer

"Mr. Wilson… you have prostate cancer." Those words made up the most devastating phrase I had ever heard. I have faced numerous challenges in my life and my journey hasn't been an easy one. I walk that journey step-by-step and prayer-by-prayer.
See all stories on this topic »

How to avoid erection problems after prostate surgery

By Kathleen Blanchard RN on May 18, 2012 – 11:42am for eMaxHealth Men who are faced with prostate surgery are also at risk for erectile dysfunction (ED) and urinary incontinence that are common side effects of prostate gland removal for cancer.
See all stories on this topic »

Dendreon stock dives after rival's cancer drug shows benefits

(May 18, 2012, by MySeattleTimesID) MORE The stock of Dendreon, maker of the prostate-cancer drug Provenge, dropped to its lowest value in four months after a study showed that Johnson & Johnson's rival medicine Zytiga helped high-risk patients.
See all stories on this topic »

Catching a killer quicker: Two new prostate cancer tests

PSA testing is one step in early identification of prostate tumors, but PSA testing can miss some cancers, or produce a false positive. A study published in the Journal of Urology, followed 900 patients from 10 sites. The results showed the new … See all stories on this topic »

KSAT San Antonio

Health Outcomes: Robotic Surgery, Prostate Cancer Treatment …

The diffusion of robotic surgery technology has coincided with a rapid period of growth in surgical treatment of prostate cancer, and this has raised questions of …
www.mskcc.org/…/robotic-surgery-prostate-treatment-p

Prostate Cancer Tops News in Humdrum ASCO Abstract Release

Adding to the mix is Medivation Inc.'s MDV3100, which is set to present further data from its positive Phase III AFFIRM study in post-chemotherapy prostate cancer patients. San Francisco-based Medivation also is testing its drug in a Phase II …
See all stories on this topic »

Mount Sinai cancer researchers to present several landmark studies at ASCO meeting

Mount Sinai School of Medicine researchers will present several landmark studies, including data on treatment trends in late-stage cancer, a promising multiple myeloma vaccine, and predictive models of soft tissue sarcomas, prostate and bladder cancer, …
See all stories on this topic »

Bavarian Nordic's PROSPECT, a single global, randomized, double-blind, placebo-controlled Phase 3 study of PROSTVACR in prostate cancer patients with metastatic disease who have failed hormone therapy is also the subject of a "Trials in Progress" …
See all stories on this topic »

ZYTIGA® (abiraterone acetate) Data to be Presented at 2012 American Society of …

ZYTIGA in combination with prednisone was approved by the US Food and Drug Administration (FDA) in April 2011 for the treatment of men with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel.
See all stories on this topic »

Prostate Cancer Experts Say No to Prostatectomy

But a prominent urologist is now telling prostate cancer patients – forget the prostactecomy. What he means is, it's time for long-term studies to “scientifically, objectively and reliably inform patients as to when and how to treat localized prostate …
See all stories on this topic »

Most cases of prostate cancer curable if detected and treated early

In its earliest, most curable stage, prostate cancer has no symptoms, according to Rebecca von Goetz, executive vice-president of Prostate Cancer Canada (PCC). More than 90 per cent of prostate cancer cases are curable if detected and treated in their …
See all stories on this topic »

Bone health critical issue for men with prostate cancer

"I treat many of these men who are unaware of their risk of prostate cancer and are often diagnosed at later stages of the disease." When an African-American man is diagnosed with prostate cancer, he often has a more advanced level of the disease.
See all stories on this topic »

Catching a killer quicker: Two new prostate cancer tests

Dr. Wei: Part of it is there is a huge amount of publicity about prostate cancer and this has just been growing over the years. There's been particularly a lot of press recently about overtreatment and the burden to patients who get treated because of … See all stories on this topic »

KSAT San Antonio

Patient takes stand against Highmark

By Friday, the health insurer had done a complete turnaround and agreed to pay for Patel's full treatment, spokesman Aaron Billger told me. Highmark's change of heart, however, won't apply to other prostate cancer patients in the same predicament as …
See all stories on this topic »

'Next Generation' cancer treatment ready for clinical trials

In the Journal of Biological Chemistry, published today, the researchers outline how these new agents increase the levels of a molecule (NDRG1) which inhibits the spread of cancer, including prostate and colon cancers. "Together with a …
Medical Xpress – latest medical…

Health Outcomes: Robotic Surgery, Prostate Cancer Treatment …

The diffusion of robotic surgery technology has coincided with a rapid period of growth in surgical treatment of prostate cancer, and this has raised questions of …
www.mskcc.org/…/robotic-surgery-prostate-treatment-p

How effective is cryotherapy for treating prostate cancer? | HIFU …

However, like other forms of treatments available for prostate cancer, it has never undergone an FDA trial or formal approval, but was “grandfathered” approved …
www.hifumedicalexpert.com/blog/?p=225

of communication are incredibly important when you or someone you know has been diagnosed with cancer, but what you are actually communicating is equally important. Make sure you always have the best information available to deal with cancer. Here are some expert tips that will assist you in fighting cancer.

If you are 50 years or older, it is important that you get a colonoscopy at least once every 5 years. If you are at risk for colon cancer, it should be every two years. A colonoscopy can detect changes in the cells, and if treated early, can save your life.

African Americans are statistically more likely to develop prostate cancer, but on average are diagnosed later in life, and are less likely to trust a physician, or their treatment plan. While this may have a significant effect on the cancer outcome, …
See all stories on this topic »

Bavarian Nordic to Report New PROSTVACR Clinical Data at the American Society …

Bavarian Nordic's PROSPECT, a single global, randomized, double-blind, placebo-controlled Phase 3 study of PROSTVACR in prostate cancer patients with metastatic disease who have failed hormone therapy is also the subject of a "Trials in Progress" …
See all stories on this topic »

ZYTIGA® (abiraterone acetate) Data to be Presented at 2012 American Society of …

ZYTIGA in combination with prednisone was approved by the US Food and Drug Administration (FDA) in April 2011 for the treatment of men with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel.
See all stories on this topic »

Prostate Cancer Experts Say No to Prostatectomy

But a prominent urologist is now telling prostate cancer patients – forget the prostactecomy. What he means is, it's time for long-term studies to “scientifically, objectively and reliably inform patients as to when and how to treat localized prostate …
See all stories on this topic »

Most cases of prostate cancer curable if detected and treated early

In its earliest, most curable stage, prostate cancer has no symptoms, according to Rebecca von Goetz, executive vice-president of Prostate Cancer Canada (PCC). More than 90 per cent of prostate cancer cases are curable if detected and treated in their …
See all stories on this topic »

Bone health critical issue for men with prostate cancer

"I treat many of these men who are unaware of their risk of prostate cancer and are often diagnosed at later stages of the disease." When an African-American man is diagnosed with prostate cancer, he often has a more advanced level of the disease.
See all stories on this topic »

Catching a killer quicker: Two new prostate cancer tests

Dr. Wei: Part of it is there is a huge amount of publicity about prostate cancer and this has just been growing over the years. There's been particularly a lot of press recently about overtreatment and the burden to patients who get treated because of … See all stories on this topic »

KSAT San Antonio

Patient takes stand against Highmark

By Friday, the health insurer had done a complete turnaround and agreed to pay for Patel's full treatment, spokesman Aaron Billger told me. Highmark's change of heart, however, won't apply to other prostate cancer patients in the same predicament as …
See all stories on this topic »

'Next Generation' cancer treatment ready for clinical trials

In the Journal of Biological Chemistry, published today, the researchers outline how these new agents increase the levels of a molecule (NDRG1) which inhibits the spread of cancer, including prostate and colon cancers. "Together with a …
Medical Xpress – latest medical…

Health Outcomes: Robotic Surgery, Prostate Cancer Treatment …

The diffusion of robotic surgery technology has coincided with a rapid period of growth in surgical treatment of prostate cancer, and this has raised questions of …
www.mskcc.org/…/robotic-surgery-prostate-treatment-p

n other useful information and tips for dealing with cancer in this article.

Cancer patients will regain their strength after the treatment is over, even if the cancer isn’t gone, so this is a great time to actually get out there and enjoy your life. It doesn’t have to be the proverbial bucket list, but doing the things you enjoy will remind you that you should be fighting the cancer so that you can always enjoy these things.

For women, a mammogram is a great way to prevent breast cancer. A regularly schedule mammogram allows doctors to detect any lumps in breast tissue. Lumps in the breast tissue are a possible sign of breast cancer. Self breast exams should also be performed by women at home.

To avoid being diagnosed with skin cancer, you should strive to wear sunscreen with a minimum SPF of 30 when you are out in the sun. Melanoma and skin cancer are caused frequently due to neglectful people forgetting to apply sunscreen. By performing this simple task, you can protect your health a great deal.

Beware that breast cancer can occur in women of all ages. Many women think that because they are in their twenties or thirties that they cannot get breast cancer, therefore, they ignore symptoms, like lumps in their breasts. If you feel anything suspicious, be sure to let your doctor know.

There is just so much to cover with a topic like cancer that you may never be able to learn it all. However, you can learn some great ways to deal with the disease either by pretreatment options or tactics you can use if diagnosed with the disease. This article has taught you some of them, so make sure you refer back to these tips if you ever need them.

By Post-Bulletin staff Researchers at Mayo Clinic say they have discovered biomarkers that they hope will allow them to develop a test for prostate cancer that tells whether the cancer needs treatment. They published their study results in the journal …
See all stories on this topic »

J&J's Zytiga Helps Eliminate Early-Stage Prostate Cancer

By Michelle Fay Cortez on May 17, 2012 Johnson & Johnson (JNJ) (JNJ)'s Zytiga, approved last year to treat metastatic prostate cancer, helped eliminate tumors in high-risk patients whose malignancy hadn't yet spread, a small study found.
See all stories on this topic »

Tokai Pharmaceuticals' Galeterone Phase 1 Data in Patients with …

Galeterone is a proprietary small molecule, oral drug for the treatment of CRPC that disrupts the growth and survival of prostate cancer cells via a novel triple mechanism of action. The study findings, presented for the first time last month at the …
Drugs.com – Clinical Trials

Bavarian Nordic to Report New PROSTVACR Clinical Data at the American Society …

Bavarian Nordic's PROSPECT, a single global, randomized, double-blind, placebo-controlled Phase 3 study of PROSTVACR in prostate cancer patients with metastatic disease who have failed hormone therapy is also the subject of a "Trials in Progress" …
See all stories on this topic »

Active Biotech and Ipsen to present Tasquinimod Phase II Overall Survival data …

The presentation will provide overall survival (OS) data from the tasquinimod Phase II study in chemotherapy-naïve metastatic castrate resistant prostate cancer (CRPC). The poster "Tasquinimod and survival in men with metastatic castration-resistant …
See all stories on this topic »

Prostate Cancer Risk Calculator offers men 'individual risk assessment'

The multi-step Prostate Cancer Risk Calculator, www.prostatecancer-riskcalculator.com*, has been created by the founders of the European Randomized Study of Screening for Prostate Cancer (ERSPC). It is easy and simple for people to use.
See all stories on this topic »

ZYTIGA® (abiraterone acetate) Data to be Presented at 2012 American Society of …

Interim analysis (IA) results of COU-AA-302, a randomized, phase 3 study of abiraterone acetate (AA) in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) (Abstract LBA 4518)Clinical Science Symposium: New …
See all stories on this topic »

Bone health critical issue for men with prostate cancer

When an African-American man is diagnosed with prostate cancer, he often has a more advanced level of the disease. In fact, a study looking at how prostate cancer can spread to other parts of the body found that African-American men were more likely …
See all stories on this topic »

Charlie Wilson's fight against prostate cancer

"Mr. Wilson… you have prostate cancer." Those words made up the most devastating phrase I had ever heard. I have faced numerous challenges in my life and my journey hasn't been an easy one. I walk that journey step-by-step and prayer-by-prayer.
See all stories on this topic »

How to avoid erection problems after prostate surgery

By Kathleen Blanchard RN on May 18, 2012 – 11:42am for eMaxHealth Men who are faced with prostate surgery are also at risk for erectile dysfunction (ED) and urinary incontinence that are common side effects of prostate gland removal for cancer.
See all stories on this topic »

cancer, or who has just freshly been diagnosed, there is a lot of fear of what you can and can’t do. This article will give you some advice on how to deal with your cancer and the myriad of issues that come with it.

Today the development of tasquinimod is principally focused on the treatment of prostate cancer. It was announced in December 2009 that the primary endpoint of the Phase II clinical study, to show a higher fraction of patients with no disease …
See all stories on this topic »

Racial Differences in Cancer Treatment

African Americans are statistically more likely to develop prostate cancer, but on average are diagnosed later in life, and are less likely to trust a physician, or their treatment plan. While this may have a significant effect on the cancer outcome, …
See all stories on this topic »

Bavarian Nordic to Report New PROSTVACR Clinical Data at the American Society …

Bavarian Nordic's PROSPECT, a single global, randomized, double-blind, placebo-controlled Phase 3 study of PROSTVACR in prostate cancer patients with metastatic disease who have failed hormone therapy is also the subject of a "Trials in Progress" …
See all stories on this topic »

ZYTIGA® (abiraterone acetate) Data to be Presented at 2012 American Society of …

ZYTIGA in combination with prednisone was approved by the US Food and Drug Administration (FDA) in April 2011 for the treatment of men with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel.
See all stories on this topic »

Prostate Cancer Experts Say No to Prostatectomy

But a prominent urologist is now telling prostate cancer patients – forget the prostactecomy. What he means is, it's time for long-term studies to “scientifically, objectively and reliably inform patients as to when and how to treat localized prostate …
See all stories on this topic »

Most cases of prostate cancer curable if detected and treated early

In its earliest, most curable stage, prostate cancer has no symptoms, according to Rebecca von Goetz, executive vice-president of Prostate Cancer Canada (PCC). More than 90 per cent of prostate cancer cases are curable if detected and treated in their …
See all stories on this topic »

Bone health critical issue for men with prostate cancer

"I treat many of these men who are unaware of their risk of prostate cancer and are often diagnosed at later stages of the disease." When an African-American man is diagnosed with prostate cancer, he often has a more advanced level of the disease.
See all stories on this topic »

Catching a killer quicker: Two new prostate cancer tests

Dr. Wei: Part of it is there is a huge amount of publicity about prostate cancer and this has just been growing over the years. There's been particularly a lot of press recently about overtreatment and the burden to patients who get treated because of … See all stories on this topic »

KSAT San Antonio

Patient takes stand against Highmark

By Friday, the health insurer had done a complete turnaround and agreed to pay for Patel's full treatment, spokesman Aaron Billger told me. Highmark's change of heart, however, won't apply to other prostate cancer patients in the same predicament as …
See all stories on this topic »

'Next Generation' cancer treatment ready for clinical trials

In the Journal of Biological Chemistry, published today, the researchers outline how these new agents increase the levels of a molecule (NDRG1) which inhibits the spread of cancer, including prostate and colon cancers. "Together with a …
Medical Xpress – latest medical…

earning to deal with cancer, whether to support a loved one or facing a diagnosis, is crucial to living with it. You can never have enough knowledge about the subject, though you might know more than you want at times. Use these ideas to help as you confront it.

If you have cancer and expect to be going through chemotherapy then make sure your doctor prescribed some medication to you for nausea. Nausea is one of the most common side effects of chemo and bouts of it can be quite severe. Some good options are zofran, phenergan, and meclizine.

Who is the ideal prostate cancer patient for CyberKnife?
media.medstargeorgetown.org/…/Dr.%20Sean%20P.%20Colli…

A Meeting of the Medical Minds

Nancy Dawson is director of clinical research at the Prostate Cancer Research and Treatment Center, a subsidiary of the larger Georgetown Lombardi Comprehensive Cancer Center. At Georgetown, she continues to develop innovative approaches to treating …
See all stories on this topic »

Active Biotech and Ipsen to present Tasquinimod Phase II Overall Survival data …

Today the development of tasquinimod is principally focused on the treatment of prostate cancer. It was announced in December 2009 that the primary endpoint of the Phase II clinical study, to show a higher fraction of patients with no disease …
See all stories on this topic »

Racial Differences in Cancer Treatment

African Americans are statistically more likely to develop prostate cancer, but on average are diagnosed later in life, and are less likely to trust a physician, or their treatment plan. While this may have a significant effect on the cancer outcome, …
See all stories on this topic »

Bavarian Nordic to Report New PROSTVACR Clinical Data at the American Society …

Bavarian Nordic's PROSPECT, a single global, randomized, double-blind, placebo-controlled Phase 3 study of PROSTVACR in prostate cancer patients with metastatic disease who have failed hormone therapy is also the subject of a "Trials in Progress" …
See all stories on this topic »

ZYTIGA® (abiraterone acetate) Data to be Presented at 2012 American Society of …

ZYTIGA in combination with prednisone was approved by the US Food and Drug Administration (FDA) in April 2011 for the treatment of men with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel.
See all stories on this topic »

Prostate Cancer Experts Say No to Prostatectomy

But a prominent urologist is now telling prostate cancer patients – forget the prostactecomy. What he means is, it's time for long-term studies to “scientifically, objectively and reliably inform patients as to when and how to treat localized prostate …
See all stories on this topic »

Most cases of prostate cancer curable if detected and treated early

In its earliest, most curable stage, prostate cancer has no symptoms, according to Rebecca von Goetz, executive vice-president of Prostate Cancer Canada (PCC). More than 90 per cent of prostate cancer cases are curable if detected and treated in their …
See all stories on this topic »

Bone health critical issue for men with prostate cancer

"I treat many of these men who are unaware of their risk of prostate cancer and are often diagnosed at later stages of the disease." When an African-American man is diagnosed with prostate cancer, he often has a more advanced level of the disease.
See all stories on this topic »

Catching a killer quicker: Two new prostate cancer tests

Dr. Wei: Part of it is there is a huge amount of publicity about prostate cancer and this has just been growing over the years. There's been particularly a lot of press recently about overtreatment and the burden to patients who get treated because of … See all stories on this topic »

KSAT San Antonio

]]> http://www.prostatecancernews.net/catching-a-killer-quicker-two-new-prostate-cancer-tests.html/feed 0 http://www.prostatecancernews.net/bone-health-critical-issue-for-men-with-prostate-cancer.html http://www.prostatecancernews.net/bone-health-critical-issue-for-men-with-prostate-cancer.html#comments Sun, 20 May 2012 06:26:57 +0000 rob http://www.prostatecancernews.net/bone-health-critical-issue-for-men-with-prostate-cancer.html

Read the rest of this entry

"This is one of the first — if not the first — study to show that you can make prostate cancer in the prostate gland itself disappear in a reproducible number of …
health.yahoo.net/…/advanced-prostate-cancer-drug-may-help-…

Study Shows J&J's Zytiga Can Eliminate Some Prostate Tumors; Drug Combinations …

WASHINGTON (Dow Jones)–A study looking at small group of men with prostate cancer showed the use of Johnson & Johnson's (JNJ) Zytiga eliminated or greatly reduced the size of prostate tumors in one-third of patients treated for six months before …
See all stories on this topic »

A Meeting of the Medical Minds

Nancy Dawson is director of clinical research at the Prostate Cancer Research and Treatment Center, a subsidiary of the larger Georgetown Lombardi Comprehensive Cancer Center. At Georgetown, she continues to develop innovative approaches to treating …
See all stories on this topic »

Dendreon stock dives after rival's cancer drug shows benefits

By Ryan Flinn The stock of Dendreon, maker of the prostate-cancer drug Provenge, dropped to its lowest value in four months after a study showed that Johnson & Johnson's rival medicine Zytiga helped high-risk patients. Dendreon shares fell 97 cents, …
See all stories on this topic »

A better test for prostate cancer?

By Post-Bulletin staff Researchers at Mayo Clinic say they have discovered biomarkers that they hope will allow them to develop a test for prostate cancer that tells whether the cancer needs treatment. They published their study results in the journal …
See all stories on this topic »

J&J's Zytiga Helps Eliminate Early-Stage Prostate Cancer

By Michelle Fay Cortez on May 17, 2012 Johnson & Johnson (JNJ) (JNJ)'s Zytiga, approved last year to treat metastatic prostate cancer, helped eliminate tumors in high-risk patients whose malignancy hadn't yet spread, a small study found.
See all stories on this topic »

Tokai Pharmaceuticals' Galeterone Phase 1 Data in Patients with …

Galeterone is a proprietary small molecule, oral drug for the treatment of CRPC that disrupts the growth and survival of prostate cancer cells via a novel triple mechanism of action. The study findings, presented for the first time last month at the …
Drugs.com – Clinical Trials

Bavarian Nordic to Report New PROSTVACR Clinical Data at the American Society …

Bavarian Nordic's PROSPECT, a single global, randomized, double-blind, placebo-controlled Phase 3 study of PROSTVACR in prostate cancer patients with metastatic disease who have failed hormone therapy is also the subject of a "Trials in Progress" …
See all stories on this topic »

Active Biotech and Ipsen to present Tasquinimod Phase II Overall Survival data …

The presentation will provide overall survival (OS) data from the tasquinimod Phase II study in chemotherapy-naïve metastatic castrate resistant prostate cancer (CRPC). The poster "Tasquinimod and survival in men with metastatic castration-resistant …
See all stories on this topic »

Prostate Cancer Risk Calculator offers men 'individual risk assessment'

The multi-step Prostate Cancer Risk Calculator, www.prostatecancer-riskcalculator.com*, has been created by the founders of the European Randomized Study of Screening for Prostate Cancer (ERSPC). It is easy and simple for people to use.
See all stories on this topic »